Cisplatin
Showing 1 - 25 of 4,414
Breast Cancer Trial in Shanghai (ABX, cisplatin, Gemcitabine, Cisplatin)
Completed
- Breast Cancer
- ABX, cisplatin
- Gemcitabine, Cisplatin
-
Shanghai, ChinaFudan University Cancer Hospital
Apr 20, 2022
Nasopharyngeal Cancer Trial in Singapore (cisplatin and gemcitabine, induction chemo cisplatin, gemcitabine, bevacizumab and
Not yet recruiting
- Nasopharyngeal Cancer
- cisplatin and gemcitabine
- induction chemotherapy cisplatin, gemcitabine, bevacizumab and pembrolizumab.
-
Singapore, SingaporeNational University Hospital
Mar 22, 2022
Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)
Not yet recruiting
- Chemotherapy；Advanced Gastric Cancer；Cisplatin；Disulfiram
- disulfiram and cisplatin
- cisplatin
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Dec 26, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Strasbourg (Split Cisplatin, Cisplatin, Radiotherapy)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- Split Cisplatin
- +2 more
-
Strasbourg, FranceCentre Paul Strauss
Mar 10, 2022
Pentoxifylline, Cisplatin, Nephrotoxixcity Trial (Pentoxifylline 400 mg SR tablets, cisplatin with standard hydration with
Not yet recruiting
- Pentoxifylline, Cisplatin, Nephrotoxixcity
- Pentoxifylline 400 mg SR tablets
- cisplatin with standard hydration with normal saline
- (no location specified)
Nov 30, 2022
Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)
Not yet recruiting
- Biliary Tract Neoplasms
- Envafolimab plus Gemcitabine&Cisplatin
- Gemcitabine&Cisplatin
- (no location specified)
Jun 8, 2022
Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Recurrent or Metastatic
- KL-A167
- +3 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022
MGMT-Unmethylated Glioblastoma Trial (Etoposide Plus Cisplatin)
Not yet recruiting
- MGMT-Unmethylated Glioblastoma
- Etoposide Plus Cisplatin
- (no location specified)
Jan 12, 2023
Cisplatin Adverse Reaction Trial in Tanta (cisplatin with hydration magnesium)
Enrolling by invitation
- Cisplatin Adverse Reaction
- cisplatin with hydration magnesium
-
Tanta, Gharbiya, EgyptMohamed Saad younis
Oct 25, 2022
Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Camrelizumab)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
-
Zhengzhou, Henan, ChinaDepartment of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 3, 2022
Nasopharyngeal Carcinoma Trial in Wuhan (raltitrexed-cisplatin, Intensity-modulated radiotherapy (IMRT))
Completed
- Nasopharyngeal Carcinoma
- raltitrexed-cisplatin
- Intensity-modulated radiotherapy (IMRT)
-
Wuhan, Hubei, ChinaHubei Cancer hospital
Feb 4, 2022
Hepatocellular Carcinoma Trial in Hong Kong (Cisplatin)
Recruiting
- Hepatocellular Carcinoma
- Cisplatin
-
Hong Kong, Hong KongDepartment of Imaging and Interventional Radiology, Prince of Wa
Mar 10, 2022
ERCC1 and OCT2 on Occurrence and Severity of Cisplatin-induced
Not yet recruiting
- Cisplatin Adverse Reaction
- ERCC1
- OCT2
-
Cairo, EgyptFaculty of medicine, Ain Shams University
Feb 9, 2022
Advanced Malignant Solid Tumors Trial in Changchun (Cisplatin micelle injection (HA132))
Not yet recruiting
- Advanced Malignant Solid Tumors
- Cisplatin micelle injection (HA132)
-
Changchun, Jilin, ChinaJilin Cancer Hospital
Jul 28, 2022
Penile Cancer Trial in Guangzhou (Albumin-Bound Paclitaxel, Ifosfamide, Cisplatin)
Completed
- Penile Cancer
- Albumin-Bound Paclitaxel
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 8, 2022
Advanced Gastric Carcinoma, HER2-positive Gastric Cancer Trial in ZhengZhou (RC48+AK105+cisplatin)
Not yet recruiting
- Advanced Gastric Carcinoma
- HER2-positive Gastric Cancer
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 29, 2022
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)
Active, not recruiting
- Bile Duct Cancer
- Intrahepatic Cholangiocarcinoma
- Melphalan/HDS
- Cisplatin and Gemcitabine
-
Durham, North Carolina
- +2 more
Mar 23, 2022
Combining Genomics and Imageomics to Predict Sensitivity of
Not yet recruiting
- Sensitivity
- Neoadjuvant pemetrexed and cisplatin chemotherapy
- (no location specified)
Jan 5, 2022
Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel
Completed
- Pancreatic Cancer
- +4 more
- Ascorbic Acid
- +3 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Feb 10, 2022
Cervical Cancer, Neoadjuvant Chemo Trial in Shantou (gemcitabine and cisplatin)
Recruiting
- Cervical Cancer
- Neoadjuvant Chemotherapy
- gemcitabine and cisplatin
-
Shantou, Guangdong, ChinaCancer Hospital, Shantou University Medical College
Jan 18, 2022
Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine
Active, not recruiting
- Local Advanced High Risk Nasopharyngeal Carcinoma
- IMRT combine with cisplatin concurrent chemotherapy
- IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Mar 13, 2022
Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Cisplatin
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 18, 2022
Pediatric Germ Cell Tumor Trial in Seoul (TIP treatment (paclitaxel/ifosfamide/cisplatin))
Recruiting
- Pediatric Germ Cell Tumor
- TIP treatment (paclitaxel/ifosfamide/cisplatin)
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 8, 2022